Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-110935
Filing Date
2022-10-24
Accepted
2022-10-24 16:36:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2228766d1_424b5.htm 424B5 347780
2 GRAPHIC tm2228766d1_424b5img001.jpg GRAPHIC 4375
3 GRAPHIC tm2027047d1_s3img002.jpg GRAPHIC 10026
4 GRAPHIC tm2027047d1_s3img001.jpg GRAPHIC 29328
  Complete submission text file 0001104659-22-110935.txt   409635
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-244362 | Film No.: 221326367
SIC: 2834 Pharmaceutical Preparations